Efficacy and Safety of Intracavernosal Alprostadil in Diabetic Patients with Erectile Dysfunction

Erectile dysfunction is a common complication of Diabetes Mellitus. Intracavernosal Alprostadil, the naturally occurring form of Prostaglandin E 1, has been used successfully in the treatment of erectile dysfunction. Results with Alprostadil have shown a poorer response, shorter duration of actio...

Full description

Saved in:

Bibliographic Details
Main Author:	Doshi, Sanjay Lalitchandra
Format:	Thesis
Language:	English
Published:	2001
Subjects:	RC31-1245 Internal medicine
Online Access:	http://eprints.usm.my/36699/1/DR_SANJAY_LALITCHANDRA_DOSHI.pdf
Tags:	Add Tag No Tags, Be the first to tag this record!

id	my-usm-ep.36699
record_format	uketd_dc
spelling	my-usm-ep.366992019-04-12T05:27:05Z Efficacy and Safety of Intracavernosal Alprostadil in Diabetic Patients with Erectile Dysfunction 2001 Doshi, Sanjay Lalitchandra RC31-1245 Internal medicine Erectile dysfunction is a common complication of Diabetes Mellitus. Intracavernosal Alprostadil, the naturally occurring form of Prostaglandin E 1, has been used successfully in the treatment of erectile dysfunction. Results with Alprostadil have shown a poorer response, shorter duration of action and need for higher dosage in diabetic patients with erectile dysfunction when compared to the general population. No study targeted specifically to the diabetic population has been completed with Alprostadil so far. 2001 Thesis http://eprints.usm.my/36699/ http://eprints.usm.my/36699/1/DR_SANJAY_LALITCHANDRA_DOSHI.pdf application/pdf en public masters Universiti Sains Malaysia Pusat Pengajian Sains Perubatan
institution	Universiti Sains Malaysia
collection	USM Institutional Repository
language	English
topic	RC31-1245 Internal medicine
spellingShingle	RC31-1245 Internal medicine Doshi, Sanjay Lalitchandra Efficacy and Safety of Intracavernosal Alprostadil in Diabetic Patients with Erectile Dysfunction
description	Erectile dysfunction is a common complication of Diabetes Mellitus. Intracavernosal Alprostadil, the naturally occurring form of Prostaglandin E 1, has been used successfully in the treatment of erectile dysfunction. Results with Alprostadil have shown a poorer response, shorter duration of action and need for higher dosage in diabetic patients with erectile dysfunction when compared to the general population. No study targeted specifically to the diabetic population has been completed with Alprostadil so far.
format	Thesis
qualification_level	Master's degree
author	Doshi, Sanjay Lalitchandra
author_facet	Doshi, Sanjay Lalitchandra
author_sort	Doshi, Sanjay Lalitchandra
title	Efficacy and Safety of Intracavernosal Alprostadil in Diabetic Patients with Erectile Dysfunction
title_short	Efficacy and Safety of Intracavernosal Alprostadil in Diabetic Patients with Erectile Dysfunction
title_full	Efficacy and Safety of Intracavernosal Alprostadil in Diabetic Patients with Erectile Dysfunction
title_fullStr	Efficacy and Safety of Intracavernosal Alprostadil in Diabetic Patients with Erectile Dysfunction
title_full_unstemmed	Efficacy and Safety of Intracavernosal Alprostadil in Diabetic Patients with Erectile Dysfunction
title_sort	efficacy and safety of intracavernosal alprostadil in diabetic patients with erectile dysfunction
granting_institution	Universiti Sains Malaysia
granting_department	Pusat Pengajian Sains Perubatan
publishDate	2001
url	http://eprints.usm.my/36699/1/DR_SANJAY_LALITCHANDRA_DOSHI.pdf
_version_	1747820645568217088

Efficacy and Safety of Intracavernosal Alprostadil in Diabetic Patients with Erectile Dysfunction

Similar Items